PALATIN TECHNOLOGIES, INC. Deferred Revenue (Non-Current)
PALATIN TECHNOLOGIES, INC. (PTN) had Deferred Revenue (Non-Current) of $0 as of 2019-06-30, per its 10-K filed 2019-09-12.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2019-09-12
- 2019-06-30: Deferred Revenue, Noncurrent $0.00.
- 2019-03-31: Deferred Revenue, Noncurrent $0.00.
- 2018-12-31: Deferred Revenue, Noncurrent $0.00.
- 2018-09-30: Deferred Revenue, Noncurrent $0.00.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2019-06-30 | $0.00 10-K · filed 2019-09-12 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-09 |
| 2018-12-31 | $0.00 10-Q · filed 2019-02-11 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-09 |
| 2018-06-30 | $500.00K 10-K · filed 2019-09-12 |
| 2018-03-31 | $500.00K 10-Q · filed 2018-05-14 |
| 2017-12-31 | $500.00K 10-Q · filed 2018-02-12 |
| 2017-06-30 | $0.00 10-K · filed 2018-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |